Magnesium interactions with medications
Pro Research Analysisby 
Searched over 200M research papers
Magnesium Interactions with Medications
Magnesium and Drug Absorption and Metabolism
Magnesium plays a crucial role in the body's absorption, metabolism, and elimination of various drugs. Several medications, including diuretics and proton-pump inhibitors, can lead to magnesium loss and hypomagnesemia, a condition characterized by low levels of magnesium in the blood . This interaction is significant because both magnesium and drugs often share the same transport and metabolism pathways in the body. For instance, minerals like magnesium, calcium, and zinc can interfere with the gastrointestinal absorption of tetracycline antibiotics, potentially reducing their effectiveness . Conversely, certain drugs, such as diuretics, can induce renal magnesium loss, impairing the physiological function of magnesium .
Magnesium and Psychotropic Drugs
Psychotropic drugs, including antidepressants, antimanic drugs, antipsychotics, and analgesic opioids, frequently interact with magnesium. Research indicates that patients with severe major depression have lower erythrocyte magnesium levels compared to healthy individuals . Treatment with antidepressants like sertraline and amitryptiline has been shown to significantly increase erythrocyte magnesium concentrations, suggesting a beneficial interaction . Similarly, in patients with acute paranoid schizophrenia, antipsychotic medications such as haloperidol and risperidone also increase erythrocyte magnesium levels . For patients with bipolar disorder type I, mood stabilizers like carbamazepine and sodium valproate significantly elevate magnesium levels, correlating with improved clinical outcomes . Additionally, magnesium supplementation has been found to reduce the intensity of morphine-induced physical dependence in opioid users .
Magnesium and Opioid Analgesia
Magnesium has been identified as a potential enhancer of opioid-induced analgesia, particularly in managing chronic and acute pain. Studies have shown that magnesium can increase the effectiveness of opioids in treating neuropathic and inflammatory pain, thereby reducing the required opioid dosage and minimizing the risk of side effects and overdose . Clinical trials have confirmed that magnesium supplementation can lower opioid consumption and improve postoperative pain scores without increasing the risk of adverse effects . However, further research is needed to explore the impact of magnesium on opioid activity in other challenging pain conditions .
Magnesium Sulfate and Cardiopulmonary Drug Interactions
In the context of pregnancy, the administration of magnesium sulfate (MgSO4) can lead to significant drug-drug interactions, particularly affecting cardiopulmonary function. A study involving pregnant women who received intrapartum MgSO4 identified several potentially interacting medications, including calcium channel blockers, diuretics, and antacids/laxatives . These interactions were associated with prolonged hospital stays and increased risk of cardiopulmonary complications. For example, women who received both MgSO4 and the diuretic furosemide had a higher incidence of cardiac arrest compared to those who did not receive furosemide . This highlights the need for caution when prescribing MgSO4 alongside other interacting drugs.
Magnesium and Ketamine for Pain Management
The combination of magnesium and ketamine, both NMDA-receptor antagonists, has been explored as a novel approach for treating chronic pain. Studies have shown that the interactions between these two drugs can be additive, antagonistic, or synergistic, depending on the dosages, administration times, and types of pain being treated . Despite some inconsistent results, the combination of ketamine and magnesium offers a promising therapeutic strategy for pain management, necessitating further research to standardize dosing regimens and administration protocols .
Conclusion
Magnesium interacts with a wide range of medications, affecting their absorption, metabolism, and efficacy. These interactions can have significant clinical implications, particularly in the management of pain and psychiatric conditions. Understanding these interactions is crucial for optimizing drug therapy and minimizing potential risks to patient health. Further research is needed to fully elucidate the mechanisms and clinical outcomes of these interactions, ensuring safe and effective use of magnesium in combination with other medications.
Sources and full results
Most relevant research papers on this topic
Intrapartum Magnesium Sulfate and the Potential for Cardiopulmonary Drug-Drug Interactions
Intrapartum administration of drugs that interact with magnesium sulfate is common and associated with prolonged hospital stays and potential cardiopulmonary drug-drug interactions.
Interactions Between Ketamine and Magnesium for the Treatment of Pain: Current State of the Art.
Ketamine and magnesium combined show potential for treating chronic pain, but their interactions need standardization and standardized dosing regimens to provide consistent results.
Interaction between magnesium sulfate and neuromuscular blockers during the perioperative period. A systematic review and meta-analysis.
Magnesium sulfate during general anesthesia alters neuromuscular blockade pharmacodynamics, causing a shorter onset time, prolonging clinical duration, and improving recovery time.
Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials
Oral magnesium therapy safely lowers blood pressure in uncontrolled hypertensive patients taking antihypertensive medications, but not in controlled or normotensive individuals.
A synergistic interaction between magnesium sulphate and ketamine on the inhibition of acute nociception in rats.
Magnesium sulphate and ketamine together can effectively inhibit acute nociceptive pain in rats when administered together at low doses and proportions.
Effect of Magnesium Supplementation on Chronic Kidney Disease-Mineral and Bone Disorder in Hemodialysis Patients: A Meta-Analysis of Randomized Controlled Trials.
Magnesium supplementation can improve chronic kidney disease-mineral bone disorder by regulating serum calcium and PTH metabolism and decreasing carotid intima-media thickness in hemodialysis patients.
DOI